Aastrom biosciences. The numbers are bad and the company doesn't make any money.... yet. They deal in tissue regeneration by means of stem cells (harvested from the patients bone marrow). They're currently in the process of 3 clinical trials with a 4th scheduled to begin in late 07. interim data from the long bone tissue regeneration trial boasts a 90% success rate among patients with which traditional invasive proceedurs failed. I'm just watching this stock right now.

unmanned aircraft developer and manufacturer. they're currently under contract with the department of defense (dod) for 5 different uav's. they make the smallest uav's the military uses. it weighs 7.5 ounces. with the dod planning to increase its spending on uavs for a LONG time I like this stock long term.